2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
S

2020 ASCO Update on Recurrent Ovarian Cancer: Who Should Have a Secondary Cytoreduction?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Sarah Temkin
By 2020 ASCO Virtual Direct™ Highlights FEATURING Sarah Temkin
59 views
July 16, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
GYN
14:29

2020 ASCO Update on Recurrent Ovarian Cancer: Who Should Have a Seco…

2020 ASCO Virtual Direct™ Highlights

S. Temkin

59 views
15:50

2020 ASCO Update on PARPi in Ovarian Cancer: Is BRCA Related to Ther…

2020 ASCO Virtual Direct™ Highlights

S. Temkin

82 views
08:11

2020 ASCO Update: What Is the Long-term Oncological Safety of SNL Bi…

2020 ASCO Virtual Direct™ Highlights

S. Temkin

25 views